Evidence map›Paper›PMID 23897118›Full record

ArticleImmunology and cell biology2013

MicroRNA-146a and RBM4 form a negative feed-forward loop that disrupts cytokine mRNA translation following TLR4 responses in human THP-1 monocytes.

Laura Brudecki, Donald A Ferguson, Charles E McCall, Mohamed El Gazzar

RetractedOpen access · greenAbstract read
In one paragraph

Article in Immunology and cell biology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It has been retracted, and should not be counted. Cited by 32 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed, 3 pooled it
2.2field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 3 syntheses or guidelines pooled it, 54 citations in OpenAlex.

  1. Pooled it
  2. MicroRNAs and Sepsis-Induced Cardiac Dysfunction: A Systematic Review.International journal of molecular sciences · 2020
    Pooled it
  3. Pooled it
  4. Heliyon · 2025
    Article
  5. Review
  6. Article
  7. Article
  8. Role of miRNA dysregulation in sepsis.Molecular medicine (Cambridge, Mass.) · 2022
    Review
  9. Article
  10. The role of bacterial translocation in sepsis: a new target for therapy.Therapeutic advances in gastroenterology · 2022
    Review
  11. Review
  12. Review
  13. Review
  14. Posttranscriptional regulation of human endogenous retroviruses by RNA-binding motif protein 4, RBM4.Proceedings of the National Academy of Sciences of the United States of America · 2020
    Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Laura BrudeckiDepartment of Internal Medicine, East Tennessee State University College of Medicine, Johnson City, TN, USA.
Donald A Ferguson
Charles E McCall
Mohamed El Gazzar
East Tennessee State University · USWake Forest University · US

Funding

NF-kB and Chromatin Changes in Human SepsisR01AI065791 · NIAID · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI MCCALL, CHARLES EMORY · 2006 to 2015
$4.3M
TLR4-dependent reprogramming of translation regulates acute systemic inflammationR15GM100322 · NIGMS · EAST TENNESSEE STATE UNIVERSITY · PI ELGAZZAR, MOHAMED A. · 2012 to 2012
$344k
NIAID NIH HHS R01 AI065791NIGMS NIH HHS R15 GM100322NIGMS NIH HHS R15GM100322
6 · The paper itself

Abstract

Within hours after its initiation, the severe systemic inflammatory response of sepsis shifts to an adaptive anti-inflammatory state with coincident immunosuppression. This anti-inflammatory phenotype is characterized by diminished proinflammatory cytokine gene expression in response to toll-like receptor (TLR) stimulation with bacterial endotoxin/lipopolysaccharide (LPS), also known as endotoxin tolerance/adaptation. Our and other studies have established that gene-specific reprogramming following TLR4 responses independently represses transcription and translation of proinflammatory genes such as tumor necrosis factor alpha (TNFα). We also previously demonstrated that TNFα and interleukin (IL)-6 mRNA translation is repressed in endotoxin-adapted THP-1 human monocytes by an miRNA-based mechanism involving the argonaute family protein argonaute 2 (Ago2). Here, we further define the molecular nature of reprogramming translation by showing that TLR4-induced microRNA-146 promotes a feed-forward loop that modifies the subcellular localization of the RNA-binding protein RBM4 (RNA-binding motif protein 4) and promotes its interaction with Ago2. This interaction results in the assembly of a translation-repressor complex that disrupts TNFα and IL-6 cytokine synthesis in endotoxin-adapted THP-1 monocytes. This novel molecular path prevents the phosphorylation of RBM4 on serine-309 by p38 MAPK (mitogen-activated protein kinase), which leads to RBM4 accumulation in the cytosol and interaction with Ago2. We further find that microRNA-146a knockdown by antagomirs or protein phosphatase inhibition by okadaic acid increases p38 MAPK phosphorylation and results in RBM4 serine-309 phosphorylation and nuclear relocalization, which disrupts RBM4 and Ago2 interactions and restores TLR4-dependent synthesis of TNFα and IL-6. We conclude that miR-146a has a diverse and critical role in limiting an excessive acute inflammatory reaction.

Indexed as

Adaptive ImmunityArgonaute ProteinsCell DifferentiationCell LineCell NucleusCytosolEndotoxinsFeedback, PhysiologicalGene Expression RegulationHomeostasisHumansImmune ToleranceInflammation MediatorsInterleukin-6MicroRNAsMonocytesAGO2 protein, humanArgonaute ProteinsEndotoxinsInflammation MediatorsInterleukin-6MicroRNAsMIRN146 microRNA, humanp38 Mitogen-Activated Protein KinasesRBM4 protein, humanRNA-Binding ProteinsRNA, MessengerTLR4 protein, humanToll-Like Receptor 4Tumor Necrosis Factor-alpha

Identifiers

PMID23897118
PMCPMC3770753
OpenAlexW2077881218

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.